2nd Quarter - Report

GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Period 2nd Quarter 2011 Filed Jul 20, 2011 Signed by Cristin Lis

Official filing
Firm
GILEAD SCIENCES, INC.
Client
GILEAD SCIENCES INC
Income
—
Expenses
$390,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Domestic HIV Policy issues: HIV/AIDS Technology Transfer and Patent Rights; HIV Testing and Treatment; Federal Employees Health Benefits and Program Coverage for Routine HIV screening; HIV/AIDS Funding - Department of Defense and Full-Year Continuing Appropriations Act, 2011. Health Care Reform ( Patient Protection and Affordable Care Act - P.L.111-148; Health Care and Education Affordability Reconciliation Act - P.L.111-152); Hepatitis B Funding for Screening and Linkage to Care Programs; International HIV and Health issues; International Trade and Intellectual Property Rights issues.

LobbyistCovered position, as disclosed
CRISTIN LIS —
REKHA RAMESH —

Contacted: SENATE; State, Dept of (DOS); Commerce, Dept of (DOC); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.